These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD. Elizondo G; Matern D; Vockley J; Harding CO; Gillingham MB Mol Genet Metab; 2020; 131(1-2):90-97. PubMed ID: 32928639 [TBL] [Abstract][Full Text] [Related]
5. Impact of newborn screening for fatty acid oxidation disorders on neurological outcome: A Belgian retrospective and multicentric study. Everard E; Laeremans H; Boemer F; Marie S; Vincent MF; Dewulf JP; Debray FG; De Laet C; Nassogne MC Eur J Paediatr Neurol; 2024 Mar; 49():60-65. PubMed ID: 38377647 [TBL] [Abstract][Full Text] [Related]
6. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency. Yamada K; Taketani T J Hum Genet; 2019 Feb; 64(2):73-85. PubMed ID: 30401918 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency. Laforêt P; Acquaviva-Bourdain C; Rigal O; Brivet M; Penisson-Besnier I; Chabrol B; Chaigne D; Boespflug-Tanguy O; Laroche C; Bedat-Millet AL; Behin A; Delevaux I; Lombès A; Andresen BS; Eymard B; Vianey-Saban C Neuromuscul Disord; 2009 May; 19(5):324-9. PubMed ID: 19327992 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience. Maguolo A; Rodella G; Dianin A; Nurti R; Monge I; Rigotti E; Cantalupo G; Salviati L; Tucci S; Pellegrini F; Molinaro G; Lupi F; Tonin P; Pasini A; Campostrini N; Ion Popa F; Teofoli F; Vincenzi M; Camilot M; Piacentini G; Bordugo A Mol Genet Metab Rep; 2020 Sep; 24():100632. PubMed ID: 32793418 [TBL] [Abstract][Full Text] [Related]
9. Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era. Janeiro P; Jotta R; Ramos R; Florindo C; Ventura FV; Vilarinho L; Tavares de Almeida I; Gaspar A Eur J Pediatr; 2019 Mar; 178(3):387-394. PubMed ID: 30617651 [TBL] [Abstract][Full Text] [Related]
10. Muscle MRI in patients with long-chain fatty acid oxidation disorders. Diekman EF; van der Pol WL; Nievelstein RA; Houten SM; Wijburg FA; Visser G J Inherit Metab Dis; 2014 May; 37(3):405-13. PubMed ID: 24305961 [TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening. Kang E; Kim YM; Kang M; Heo SH; Kim GH; Choi IH; Choi JH; Yoo HW; Lee BH BMC Pediatr; 2018 Mar; 18(1):103. PubMed ID: 29519241 [TBL] [Abstract][Full Text] [Related]
12. [Clinical features and ACADVL gene mutation spectrum analysis of 11 Chinese patients with very long chain acyl-CoA dehydrogenase deficiency]. Jinjun C; Wenjuan Q; Ruinan Z; Jun Y; Lianshu H; Huiwen Z; Qigang Z; Xuefan G Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):262-7. PubMed ID: 26182500 [TBL] [Abstract][Full Text] [Related]
13. Performance of serum and dried blood spot acylcarnitine profiles for detection of fatty acid β-oxidation disorders in adult patients with rhabdomyolysis. Al-Thihli K; Sinclair G; Sirrs S; Mezei M; Nelson J; Vallance H J Inherit Metab Dis; 2014 Mar; 37(2):207-13. PubMed ID: 23296367 [TBL] [Abstract][Full Text] [Related]
14. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients. Baruteau J; Sachs P; Broué P; Brivet M; Abdoul H; Vianey-Saban C; Ogier de Baulny H J Inherit Metab Dis; 2013 Sep; 36(5):795-803. PubMed ID: 23053472 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency. Suyama T; Shimura M; Fushimi T; Kuranobu N; Ichimoto K; Matsunaga A; Takayanagi M; Murayama K Mol Genet Metab Rep; 2020 Sep; 24():100610. PubMed ID: 32509533 [TBL] [Abstract][Full Text] [Related]
16. Genetic characteristics and follow-up of patients with fatty acid β-oxidation disorders through expanded newborn screening in a Northern Chinese population. Wang S; Leng J; Diao C; Wang Y; Zheng R J Pediatr Endocrinol Metab; 2020 May; 33(6):683-690. PubMed ID: 32447334 [TBL] [Abstract][Full Text] [Related]
18. [A case of very long chain acyl-CoA dehydrogenase deficiency diagnosed due to a trigger of hyperemesis gravidarum during pregnancy]. Shiraishi W; Tateishi T; Hayashida S; Tajima G; Tsumura M; Isobe N Rinsho Shinkeigaku; 2023 Oct; 63(10):656-660. PubMed ID: 37779023 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids. Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520 [TBL] [Abstract][Full Text] [Related]